v3.25.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 3,625 $ 13,199
Marketable securities 73,607 82,376
Total Current Assets 77,232 95,575
Total Assets 77,232 95,575
Current Liabilities    
Accounts payable and accrued expenses 778,478 780,148
Total Current Liabilities 5,300,886 5,166,681
Total Liabilities 5,300,886 5,166,681
Stockholders’ Deficit    
Common stock, $0.0001 par value: authorized 500,000,000, 21,674,000 and 21,674,000 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 2,167 2,167
Additional paid-in capital 810,048 810,048
Accumulated deficit (6,035,869) (5,883,321)
Total Stockholders’ Deficit (5,223,654) (5,071,106)
Total Liabilities and Stockholders’ Deficit 77,232 95,575
Notes Payable One [Member]    
Current Liabilities    
Convertible notes payable – related party – net of debt discount 525,000 525,000
Notes Payable Two [Member]    
Current Liabilities    
Convertible notes payable – related party – net of debt discount 173,192 173,192
Related Party [Member]    
Current Liabilities    
Accounts expenses – related party 1,026,649 938,774
Accounts payable - related party 911,659 911,659
Short -term advances - related party 1,779,058 1,731,058
Convertible notes payable – related party – net of debt discount 173,192 173,192
Notes payable - related party $ 106,850 $ 106,850

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL